Real-world study of immunotherapy in PARPi-pretreated platinum-resistant recurrent epithelial ovarian cancer

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 0d5a2a96a6cef22df13e182d90fb745db53a02e2
First added on: Oct 10, 2026